RecruitingPhase 2NCT06233461A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseSponsor: TakedaClearwater, FL · Lakeland, FL · Miami Lakes, FL · +27 more sites
RecruitingPhase 3NCT07499232A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseSponsor: Janssen Research & Development, LLCJacksonville, FL · Miami, FL · +36 more sites
RecruitingPhase 3NCT06227910A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseSponsor: TakedaNaples, FL · Orlando, FL · Tampa, FL · +16 more sites